Incongruent Treatment of Biotech Patent Holders
Like Shari Nickles

Incongruent Treatment of Biotech Patent Holders

Incongruent Treatment of Biotech Patent Holders

Description:

Published: May 16, 2016 0 0 602
By: Shari Nickles, Cal State San Marcos
Category: Food Sciences
Hashtags: #Biotechnology #monsanto #patentlaw

Examination of incongruence of inequitably preferential treatment of Monsanto as patent holder under U.S. biotechnological patent law with strict enforcement of property rights for intentional and unintentional use of patented genetically modified seeds, with lack of associated liability for harm caused by patented seeds, primarily to organic farmers, and presumption of burden of mitigation of damages on damaged parties rather than Monsanto.

Attachments:

Researchpaper.docx 41.5 KB